| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |